Pharmatel Fresenius Kabi

Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company's portfolio includes a comprehensive range of intravenous generic drugs, infusion therapies, and clinical nutrition products, alongside the medical devices required for their administration. Following the acquisition of Pharmatel in Australia, the company strengthened its presence in the Oceania region, focusing on the supply of essential hospital pharmaceuticals and anesthesia products. Fresenius Kabi is also a significant player in the biosimilars market, developing treatments for autoimmune diseases and oncology. Their operations encompass research, development, and large-scale manufacturing of sterile injectables and complex formulations. The company serves critically and chronically ill patients across various settings, including hospitals and outpatient clinics.